During the past decade, Barbara Davis Center for Childhood Diabetes conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 58 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 31 clinical trials were completed. i.e. 83.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barbara Davis Center for Childhood Diabetes" #1 sponsor was "University of Colorado, Denver" with 23 trials, followed by "Jaeb Center for Health Research" with 19 trials sponsored, "Medtronic Diabetes" with 18 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 12 trials sponsored and "DexCom, Inc." with 12 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barbara Davis Center for Childhood Diabetes" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 27 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 21 trials as a collaborator, "Jaeb Center for Health Research" with 11 trials as a collaborator, "The Leona M. and Harry B. Helmsley Charitable Trust" with 9 trials as a collaborator and "DexCom, Inc." with 8 trials as a collaborator. Other collaborators include 119 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "Barbara Davis Center for Childhood Diabetes" are "Type 1 Diabetes" (42 trials), "Type 1 Diabetes Mellitus" (32 trials), "Diabetes Mellitus, Type 1" (28 trials), "Diabetes Mellitus" (14 trials) and "Diabetes" (5 trials). Many other conditions were trialed in "Barbara Davis Center for Childhood Diabetes" in a lesser frequency.

Most popular intervention types in "Barbara Davis Center for Childhood Diabetes" are "Device" (66 trials), "Drug" (59 trials), "Other" (16 trials), "Behavioral" (5 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Insulin Lispro" (4 trials), "Insulin Degludec" (3 trials), "LY900014" (3 trials) and "t:slim X2 with Control-IQ Technology & Dexcom G6 CGM" (3 trials). Other intervention names were less common.

The vast majority of trials in "Barbara Davis Center for Childhood Diabetes" are 145 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 19 active trials in "Barbara Davis Center for Childhood Diabetes". 1 are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 120 completed trials in Barbara Davis Center for Childhood Diabetes, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Barbara Davis Center for Childhood Diabetes, 10 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 55 trials that are defined as “Not Applicable".